MaxCyte, Inc. (AIM: MXCT)
London
· Delayed Price · Currency is GBP · Price in GBX 404.00
+10.00 (2.54%)
Jan 21, 2025, 4:35 PM GMT+1
MaxCyte Market Cap
MaxCyte has a market cap or net worth of 427.07 million as of January 22, 2025. Its market cap has decreased by -0.53% in one year.
Market Cap
427.07M
Enterprise Value
325.97M
Revenue
34.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
404.00
Market Cap Chart
Since March 29, 2016, MaxCyte's market cap has increased from 33.25M to 427.07M, an increase of 1,184.24%. That is a compound annual growth rate of 33.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 171.37B |
| GSK plc | 55.25B |
| Haleon | 33.81B |
| Smith & Nephew | 9.04B |
| ConvaTec Group | 4.92B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 1.94B |
| Oxford Nanopore Technologies | 1.48B |